A new training program, the Bachmann-Strauss Fellowship in Dystonia Research aims to grow the number of researchers focused on the movement disorder known as dystonia. Launched by the Michael J. Fox Foundation for Parkinson’s Research (MJFF),
Parkinsons Articles
Regular, Sustained Physical Activity May Help Slow Disease Progression
Regular and sustained physical activity, including daily pursuits such as walking or gardening, may help slow the progression of Parkinson’s in people with early-stage disease, a long-term follow-up study suggests. Patients who exercised regularly over five
Tapering Ropinirole Caused Me Some Scary Side Effects
I’m back! Not just figuratively, but also literally. I recently took some time off to get my health in check. I was in the process of changing medications, and my neurologist had warned me that
5 Lessons I’ve Learned on My Parkinson’s Journey
If you’re a Parkinson’s veteran, what would you tell a rookie? If you’re a rookie, what Parkinson’s lessons would you like to learn? I was diagnosed in late 2014 with young-onset Parkinson’s disease at the
Dosing Starts in Canada in Trial of DA01 for Advanced Parkinson’s
A first patient in Canada has been dosed in a Phase 1 clinical trial of DA01, a cell-based investigational therapy for advanced Parkinson’s disease by BlueRock Therapeutics. The therapy consists of surgically injecting neurons (nerve cells) that
FDA Allows Yumanity to Test Single Doses of YTX-7739
The U.S. Food and Drug Administration (FDA) has issued a partial clinical hold in response to an application by Yumanity Therapeutics requesting permission to begin clinical testing in the U.S. of YTX-7739 for Parkinson’s disease.
Identifying Our Secret Superpowers
It’s a crisp January morning when my best friend and I ask each other about our superpowers. He tells me he’s as fast as lightning, which is funny because he’s a semi-pro ultra runner. I
Skin-deep Symptoms of Parkinson’s Disease
Here in Arizona, dry, flaky, and itchy skin is a common problem because we get 335 days of sunshine. But my sister Bev, who has stage 3 Parkinson’s disease, experiences the same problems with her
Alpha-synuclein Plays ‘Critical’ Role in Immune Responses to Inflammation
The protein alpha-synuclein, which has a well-established role in the development of Parkinson’s disease, is necessary for the body to mount a normal immune response against infections. “This study provides further evidence that αS [alpha-synuclein],
Phase 2 Trial of Oral Oligomannate Will Target Gut-Brain Axis
Green Valley Pharmaceuticals will launch a multi-center Phase 2 clinical trial to investigate its seaweed-based oral compound oligomannate in people with early-stage Parkinson’s disease, according to a press release. This follows the acceptance of Green
Scientists Win $1.2M Grant to Study How Stress Can Worsen Parkinson’s
A team of scientists at the University of Cincinnati, in Ohio, has received a grant worth $1.2 million from the U.S. Department of Defense (DOD) to study how stress can affect — and worsen the
MJFF $5.2M Grant to ASU Supports Stem Cell Trial, Neuron Research
The Michael J. Fox Foundation has awarded $5.2 million to scientists at Arizona State University (ASU) to support three research projects exploring new treatment options for Parkinson’s disease. The projects will be led by Jeffrey